Food Effect Study of IDX-1197 in Healthy Subjects

Healthy Male Clinical Trial

Official title:
A Randomized, Open-label, Single-dose, Crossover Phase 1 Clinical Trial to Evaluate the Effects of Food or Ethnicity on the Pharmacokinetics and Safety/Tolerability of IDX-1197 After Single Oral Administration in Healthy Male Korean, Chinese, and Caucasian Volunteers

Status Completed

Clinical Trial Summary

Study to Evaluate the Effects of Food or Ethnicity on the Pharmacokinetics and Safety/Tolerability of IDX-1197 After Single Oral Administration in Healthy Male Korean, Chinese, and Caucasian Volunteers

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Male

Clinical Trial Details

NCT number	NCT05202912
Study type	Interventional
Source	Idience Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	January 16, 2022
Completion date	July 23, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04135898` - A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects	Phase 1
Completed	`NCT02395926` - To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers	Phase 1
Recruiting	`NCT05849311` - Phase I Trial of Envafolimab for Healthy Male Subjects	Phase 1
Active, not recruiting	`NCT06105255` - A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553	Phase 1
Completed	`NCT01651234` - A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers	Phase 1
Terminated	`NCT01359618` - Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart	Phase 1
Completed	`NCT02395913` - Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)	Phase 1
Completed	`NCT06194500` - A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants	Phase 1
Completed	`NCT04828265` - Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects	Phase 1